Publications by authors named "Areen Abu Remilah"
Crit Rev Oncol Hematol
October 2024
Article Synopsis
- The study investigates how prior treatments affect the effectiveness of new drugs for first-line metastatic breast cancer (MBC).
- It analyzes data from FDA-approved MBC trials between 2000 and 2023, focusing on overall survival rates for treatment-naïve versus previously treated patients.
- Results show no significant overall survival difference between the two groups, but treatment-naïve patients with triple-negative breast cancer experienced a notable survival benefit, suggesting a potential bias in evaluating new treatments.
